David Watson - Mar 4, 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
General Counsel
Signature
David Watson
Stock symbol
APLS
Transactions as of
Mar 4, 2025
Transactions value $
-$139,789
Form type
4
Date filed
3/6/2025, 05:17 PM
Previous filing
Jan 30, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Gift $0 -6.67K -100% $0.00 0 Mar 4, 2025 Indirect Owner (The Watson Education Trust) F1, F2
transaction APLS Common Stock Gift $0 +6.67K +200.03% $0.00 10K Mar 4, 2025 Indirect Owner (Custodial Account for Son) F1, F3
transaction APLS Common Stock Sale -$140K -5.57K -3.86% $25.10 139K Mar 5, 2025 Direct
holding APLS Common Stock 70.1K Mar 4, 2025 Indirect Owner (The David O. Watson Irrevocable Trust of 2023) F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the transfer for no value of shares from the Watson Education Trust to a custodial account held by the reporting person for the sole benefit of his minor son on March 4, 2025.
F2 The securities are held by the Watson Education Trust, for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Education Trust except to the extent of his pecuniary interest therein.
F3 This represents a custodial account held by the reporting person for the sole benefit of his minor son.
F4 The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.